Clairvest Group
Renzo G. DiCarlo, P.Eng, MBA, MiM LSE, serves as Vice President of Development at Alexion Pharmaceuticals, Inc., where focused leadership has enhanced R&D clinical trials and product development through digitization and culture change. Additionally, Renzo holds several advisory and board roles, including Chair of the Board of Directors at CLINIC 360, Head of Transformation at OncoSil Medical, and advisory positions with Ascent Global Logistics and Clinical Education Alliance. Renzo is also a Board Member at the Canadian International Fashion Film Festival and Vice-President of the Canada-Belgium Committee, supporting business growth between North America and the EU. With executive experience as CEO of BioPharma Services Inc., Renzo has a solid educational foundation, including an MBA and engineering degree from prestigious institutions such as Queen's University and the University of Toronto, alongside advanced management studies at LSE and Western University.
This person is not in any teams
This person is not in any offices
Clairvest Group
1 followers
Clairvest, a leader in the Canadian private equity industry for more than 30 years, has approximately $2.8 billion of capital under management. Clairvest partners with management to invest in profitable small and mid-sized North American companies, across a wide variety of industries. In addition to providing financing, Clairvest contributes strategic expertise and execution ability to support the growth and development of its investee partners. Clairvest realizes value through investment returns and the eventual disposition of its investments.